Financial Instruments | F. FINANCIAL INSTRUMENTS Cash Equivalents Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents. Marketable Securities Teradyne’s available-for-sale securities are classified as Level 1 and Level 2. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities. Realized losses recorded in 2015 were $0.4 million. There were no realized losses recorded in 2014 and 2013. Realized gains recorded in 2015, 2014 and 2013 were $1.7 million, $2.4 million and $1.0 million, respectively. Realized gains are included in interest income, and realized losses are included in interest expense. Unrealized gains and losses are included in accumulated other comprehensive income (loss). The cost of securities sold is based on the specific identification method. During the years ended December 31, 2015 and 2014, there were no transfers in or out of Level 1, Level 2 or Level 3 financial instruments. The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2015 and 2014: December 31, 2015 Quoted Prices Significant Significant Total (in thousands) Assets Cash $ 213,336 $ — $ — $ 213,336 Cash equivalents 49,241 2,128 — 51,369 Available for sale securities: U.S. Treasury securities — 419,958 — 419,958 Corporate debt securities — 161,634 — 161,634 U.S. government agency securities — 83,952 — 83,952 Certificates of deposit and time deposits — 43,394 — 43,394 Commercial paper — 20,308 — 20,308 Equity and debt mutual funds 13,954 — — 13,954 Non-U.S. government securities — 424 — 424 Total $ 276,531 $ 731,798 $ — $ 1,008,329 Derivative assets — 109 — 109 Total $ 276,531 $ 731,907 $ — $ 1,008,438 Liabilities Contingent consideration $ — $ — $ 37,436 $ 37,436 Derivative liabilities — 146 — 146 Total $ — $ 146 $ 37,436 $ 37,582 Reported as follows: (Level 1) (Level 2) (Level 3) Total (in thousands) Assets Cash and cash equivalents $ 262,577 $ 2,128 $ — $ 264,705 Marketable securities — 477,696 — 477,696 Long-term marketable securities 13,954 251,974 — 265,928 Prepayments — 109 — 109 $ 276,531 $ 731,907 $ — $ 1,008,438 Liabilities Other current liabilities $ — $ 146 $ — $ 146 Contingent consideration — — 15,500 15,500 Long-term contingent consideration — — 21,936 21,936 $ — $ 146 $ 37,436 $ 37,582 December 31, 2014 Quoted Prices Significant Significant Total (in thousands) Assets Cash $ 111,471 $ — $ — $ 111,471 Cash equivalents 160,218 22,567 — 182,785 Available for sale securities: U.S. Treasury securities — 402,154 — 402,154 U.S. government agency securities — 258,502 — 258,502 Corporate debt securities — 141,467 — 141,467 Commercial paper — 140,638 — 140,638 Certificates of deposit and time deposits — 49,036 — 49,036 Equity and debt mutual funds 12,333 — — 12,333 Non-U.S. government securities — 446 — 446 Total $ 284,022 $ 1,014,810 $ — $ 1,298,832 Derivative assets — 220 — 220 Total $ 284,022 $ 1,015,030 $ — $ 1,299,052 Liabilities Contingent consideration $ — $ — $ 3,350 $ 3,350 Derivative liabilities — 369 — 369 Total $ — $ 369 $ 3,350 $ 3,719 Reported as follows: (Level 1) (Level 2) (Level 3) Total (in thousands) Assets Cash and cash equivalents $ 271,689 $ 22,567 $ — $ 294,256 Marketable securities — 533,787 — 533,787 Long-term marketable securities 12,333 458,456 — 470,789 Prepayments — 220 — 220 $ 284,022 $ 1,015,030 $ — $ 1,299,052 Liabilities Other current liabilities $ — $ 369 $ — $ 369 Contingent consideration — — 895 895 Long-term other accrued liabilities — — 2,455 2,455 $ — $ 369 $ 3,350 $ 3,719 Changes in the fair value of Level 3 contingent consideration for the years ended December 31, 2015 and 2014 were as follows: Contingent Consideration (in thousands) Balance at December 31, 2013 $ 2,230 Acquisition of AIT 1,750 Fair value adjustment of ZTEC (630 ) Balance at December 31, 2014 3,350 Acquisition of Universal Robots 31,597 Fair value adjustment of ZTEC (1,600 ) Fair value adjustment of AIT (1,250 ) Fair value adjustment of Universal Robots 5,339 Balance at December 31, 2015 $ 37,436 The following table provides quantitative information associated with the fair value measurement of Teradyne’s Level 3 financial instrument: Liability December 31, Valuation Unobservable Inputs Weighted (in thousands) Contingent consideration (Universal Robots) $ 21,936 Monte Carlo Revenue for the period July 1, 2015—December 31, 2017 volatility 15% Discount Rate 5.5% Revenue for the period July 1, 2015—December 31, 2018 volatility 15% Discount Rate 5.5% Contingent consideration (AIT) $ 500 Income approach- Revenue for calendar year 2016 probability 48% Discount rate 4.7% Based on Universal Robots’ calendar 2015 EBITDA results, Teradyne will pay, in first quarter of 2016, $15 million or 100% of the eligible EBITDA contingent consideration amount. As of December 31, 2015, the significant unobservable inputs used in the Monte Carlo simulation to fair value the Universal Robots contingent consideration include forecasted revenue, revenue volatility and discount rate. Increases or decreases in the inputs would result in a higher or lower fair value measurement. The significant unobservable inputs used in the AIT fair value measurement of contingent consideration are the probabilities of successful achievement of calendar year 2016 revenue threshold and target, and a discount rate. Increases or decreases in the revenue probabilities would result in a higher or lower fair value measurement. The carrying amounts and fair values of financial instruments at December 31, 2015 and 2014 were as follows: December 31, 2015 December 31, 2014 Carrying Value Fair Value Carrying Value Fair Value (in thousands) Assets Cash and cash equivalents $ 264,705 $ 264,705 $ 294,256 $ 294,256 Marketable securities 743,624 743,624 1,004,576 1,004,576 Derivative assets 109 109 220 220 Liabilities Contingent consideration 37,436 37,436 3,350 3,350 Derivative liabilities 146 146 369 369 The fair values of accounts receivable, net and accounts payable approximate the carrying amount due to the short term nature of these instruments. The following tables summarize the composition of available for sale marketable securities at December 31, 2015 and 2014: December 31, 2015 Available-for-Sale Fair Market Cost Unrealized Unrealized Fair Market (in thousands) U.S. Treasury securities $ 421,060 $ 65 $ (1,167 ) $ 419,958 $ 379,434 Corporate debt securities 163,297 902 (2,565 ) 161,634 145,373 U.S. government agency securities 84,032 42 (122 ) 83,952 55,120 Certificates of deposit and time deposits 43,391 6 (3 ) 43,394 10,527 Commercial paper 20,298 11 (1 ) 20,308 8,646 Equity and debt mutual funds 12,996 1,119 (161 ) 13,954 2,560 Non-U.S. government securities 424 — — 424 — $ 745,498 $ 2,145 $ (4,019 ) $ 743,624 $ 601,660 Reported as follows: Cost Unrealized Unrealized Fair Market Fair Market (in thousands) Marketable securities $ 478,306 $ 38 $ (648 ) $ 477,696 $ 374,785 Long-term marketable securities 267,192 2,107 (3,371 ) 265,928 226,875 $ 745,498 $ 2,145 $ (4,019 ) $ 743,624 $ 601,660 December 31, 2014 Available-for-Sale Fair Market Cost Unrealized Unrealized Fair Market (in thousands) U.S. Treasury securities $ 402,197 $ 362 $ (405 ) $ 402,154 $ 317,771 U.S. government agency securities 258,452 135 (85 ) 258,502 104,642 Corporate debt securities 139,374 2,414 (321 ) 141,467 96,998 Commercial paper 140,616 26 (4 ) 140,638 41,747 Certificates of deposit and time deposits 49,048 11 (23 ) 49,036 20,684 Equity and debt mutual funds 10,492 1,870 (29 ) 12,333 1,234 Non-U.S. government securities 446 — — 446 — $ 1,000,625 $ 4,818 $ (867 ) $ 1,004,576 $ 583,076 Reported as follows: Cost Unrealized Unrealized Fair Market Fair Market (in thousands) Marketable securities $ 533,833 $ 99 $ (145 ) $ 533,787 $ 240,234 Long-term marketable securities 466,792 4,719 (722 ) 470,789 342,842 $ 1,000,625 $ 4,818 $ (867 ) $ 1,004,576 $ 583,076 As of December 31, 2015, the fair market value of investments with unrealized losses totaled $601.7 million. Of this value, $0.9 million had unrealized losses of $0.5 million greater than one year and $600.8 million had unrealized losses of $3.6 million for less than one year. As of December 31, 2014, the fair market value of investments with unrealized losses totaled $583.1 million. Of this value, $2.3 million had unrealized losses of $0.1 million greater than one year and $580.8 million had unrealized losses of $0.8 million for less than one year. Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments, at December 31, 2015 and 2014, were temporary. The contractual maturities of investments held at December 31, 2015 were as follows: Cost Fair Value (in thousands) Due within one year $ 478,306 $ 477,696 Due after 1 year through 5 years 209,822 209,314 Due after 5 years through 10 years 5,183 5,179 Due after 10 years 39,191 37,481 Total $ 732,502 $ 729,670 Contractual maturities of investments held at December 31, 2015, exclude $14 million of equity and debt mutual funds as they do not have a contractual maturity date. Assets measured at fair value on a non-recurring basis as of December 31, 2014 are summarized as follows: Fair Value Measurements at Reporting Period December 31, Quoted Prices Significant Significant Total Losses (in thousands) Assets Goodwill $ 273,438 $ — $ — $ 273,438 $ 98,897 Definite lived intangible assets 158,237 — — 158,237 — Long-lived assets held and used 10,189 — 10,189 — — $ 441,864 $ — $ 10,189 $ 431,675 $ 98,897 In accordance with the provisions of ASC 350-10 , “Intangibles- Goodwill and Other Derivatives Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes. To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in value of the monetary assets and liabilities denominated in foreign currencies. At December 31, 2015 and 2014, Teradyne had the following contracts to buy and sell non-U.S. currencies for U.S. dollars and other non-U.S. currencies with the following notional amounts: December 31, 2015 December 31, 2014 Buy Sell Net Buy Sell Net (in millions) Japanese Yen $ (51.9 ) $ — $ (51.9 ) $ — $ 19.7 $ 19.7 British Pound Sterling (9.5 ) — (9.5 ) — 11.7 11.7 Korean Won (5.5 ) — (5.5 ) — 4.4 4.4 Taiwan Dollar (5.0 ) — (5.0 ) (0.9 ) 5.7 4.8 Euro — 27.2 27.2 (30.6 ) — (30.6 ) Singapore Dollar — 15.0 15.0 — — — Total $ (71.9 ) $ 42.2 $ (29.7 ) $ (31.5 ) $ 41.5 $ 10.0 The fair value of the outstanding contracts was $0.0 million at December 31, 2015 and a loss of $0.1 million at December 31, 2014. In 2015 and 2014, Teradyne recorded net realized losses related to foreign currency forward contracts hedging net monetary assets and liabilities of $3.0 million and $0.2 million, respectively. In 2013, Teradyne recorded net realized gains related to foreign currency forward contracts hedging net monetary assets and liabilities of $5.9 million. Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net. The following table summarizes the fair value of derivative instruments as of December 31, 2015 and 2014: Balance Sheet Location December 31, December 31, (in thousands) Derivatives not designated as hedging instruments: Foreign exchange contracts Prepayments $ 109 $ 220 Foreign exchange contracts Other current liabilities (146 ) (369 ) Total derivatives $ (37 ) $ (149 ) The following table summarizes the effect of derivative instruments in the statement of operations recognized for the years ended December 31, 2015, 2014 and 2013. The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities denominated in foreign currencies. For the years ended December 31, 2015, 2014, and 2013, gains (losses) from the remeasurement of the monetary assets and liabilities denominated in foreign currencies were $2.5 million, $(0.9) million, and $(6.9) million, respectively. Location of Losses (Gains) December 31, December 31, December 31, (in thousands) Derivatives not designated as hedging instruments: Foreign exchange contracts Other (income) expense, net $ 3,047 $ 237 $ (5,933 ) Total derivatives $ 3,047 $ 237 $ (5,933 ) See Note G: “Debt” regarding derivatives related to the convertible senior notes. Concentration of Credit Risk Financial instruments which potentially subject Teradyne to concentrations of credit risk consist principally of cash equivalents, marketable securities, forward currency contracts and accounts receivable. Teradyne’s cash equivalents consist primarily of money market funds invested in U.S. Treasuries and government agencies. Teradyne’s fixed income available-for-sale marketable securities have a minimum rating of AA by one or more of the major credit rating agencies. Teradyne places foreign currency forward contracts with high credit-quality financial institutions in order to minimize credit risk exposure. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of geographically dispersed customers. Teradyne performs ongoing credit evaluations of its customers’ financial condition and from time to time may require customers to provide a letter of credit from a bank to secure accounts receivable. One customer comprised 10% or more of Teradyne’s accounts receivable balance as of December 31, 2015. A different customer comprised 10% or more of Teradyne’s accounts receivable balance as of December 31, 2014. Equity Interest On November 1, 2013, in connection with the acquisition of Empirix, Inc. by Thoma Bravo LLC, Teradyne sold its equity interest in Empirix, Inc., a private company, and received cash proceeds of $34.2 million which was recorded as a gain in other (income) expense, net. An additional $5.4 million of cash proceeds that was held in escrow for 15 months, for potential indemnifications to the buyer, was paid to Teradyne in February 2015 and it was recorded as a gain in other (income) expense, net in the first quarter of 2015. |